MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$216,908K Marketable securities$16,812K Inventory$4,637K Prepaid expenses andother current assets$2,512K Accounts receivable$1,113K Total current assets$241,982K Goodwill$17,351K Intangible asset, net$9,063K Right-of-use assets$1,035K Other assets$704K Property and equipment,net$146K Total assets$270,281K Total liabilities andstockholders equity$270,281K Total stockholdersequity$168,450K Total liabilities$101,831K Accumulated deficit-$614,795K Accumulated othercomprehensive loss-$122K Additional paid-in capital$783,273K Long-term debt, includingaccretion, net of discount$76,520K Total currentliabilities$23,771K Warrant liability$897K Other liabilities$526K Deferred revenue$117K Common stock, 0.001 parvalue, 500,000,000...$94K Accrued expenses$17,055K Accounts payable$5,073K Deferred revenue$910K Current portion of leaseliability$733K
Balance Sheet

X4 Pharmaceuticals, Inc (XFOR)

X4 Pharmaceuticals, Inc (XFOR)

source: myfinsight.com